Research - Cambridge, Massachusetts, United States
We firmly believe that no target is "undruggable" - rather, it is currently "undone". We are ready to share our expertise in developing comprehensive chemical equity strategies and will do "whatever it takes" to identify high-quality candidates for clinical proof-of-concept.
Gmail
Varnish
Wix
Mobile Friendly